Delusions and hallucinations in Alzheimer's disease: review of the brain decade.
暂无分享,去创建一个
[1] G. Zubenko,et al. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease , 1991, Biological Psychiatry.
[2] P. Scheltens,et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging , 1999, Journal of neurology, neurosurgery, and psychiatry.
[3] M. Albert,et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease , 1994, Neurology.
[4] T. Powell,et al. A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[5] N. Gormley,et al. Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease , 1998, International journal of geriatric psychiatry.
[6] Mental and Behavioral Disturbances in Dementia: Findings from the Cache County Study on Memory in Aging , 2000 .
[7] R. Doody,et al. Positive and negative neuropsychiatric features in Alzheimer's disease. , 1995, The Journal of neuropsychiatry and clinical neurosciences.
[8] P. Rabins,et al. Risk factors for developing atypical (schizophreniform) psychosis following stroke. , 1991, The Journal of neuropsychiatry and clinical neurosciences.
[9] J. Cummings,et al. Noncognitive neuropsychiatric syndromes in alzheimer’s disease , 1990 .
[10] A. Burns,et al. Psychiatric Phenomena in Alzheimer's Disease. I: Disorders of Thought Content , 1990, British Journal of Psychiatry.
[11] K. Marder,et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease , 1996, Neurology.
[12] W W Offen,et al. The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease. , 1997, Alzheimer disease and associated disorders.
[13] R. Leiguarda,et al. Neuropsychiatric and neuropsychological correlates of delusions in Alzheimer's disease , 1995, Psychological Medicine.
[14] G. Ramaswamy,et al. A new scale for assessing behavioral agitation in dementia , 1992, Psychiatry Research.
[15] M. Esiri,et al. Psychosis of Alzheimer’s disease is associated with elevated muscarinic M2 binding in the cortex , 2001, Neurology.
[16] K. Ishii,et al. Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease. , 1998, The Journal of neuropsychiatry and clinical neurosciences.
[17] R. Schiffer,et al. Psychiatric features in diffuse Lewy body disease , 1996, Neurology.
[18] G. Grossberg,et al. The Evolution of Psychiatric Symptoms in Alzheimer's Disease: A Natural History Study , 1996, Journal of the American Geriatrics Society.
[19] A W Toga,et al. Cerebral correlates of psychotic symptoms in Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.
[20] J. Cummings,et al. Quantitative electroencephalographic correlates of psychosis in Alzheimer disease. , 2000, Neuropsychiatry, neuropsychology, and behavioral neurology.
[21] S. Wisniewski,et al. Psychotic Symptoms in Alzheimer's Disease Are Not Associated With More Severe Neuropathologic Features , 2000, International Psychogeriatrics.
[22] G. Small,et al. Apolipoprotein E genotype and noncognitive symptoms in Alzheimer’s disease , 1999, Biological Psychiatry.
[23] J. Becker,et al. Alzheimer's disease with delusions and hallucinations , 1991, Neurology.
[24] D. Jeste,et al. A Study of Delusions in a Large Cohort of Alzheimer's Disease Patients. , 1994, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[25] J. Becker,et al. The psychotic phenomenon in probable Alzheimer's disease: a positron emission tomography study. , 2001, The Journal of neuropsychiatry and clinical neurosciences.
[26] D. G. Gorman,et al. Physostigmine ameliorates the delusions of Alzheimer's disease , 1993, Biological Psychiatry.
[27] G. Vega,et al. Apolipoprotein eϵ4, other risk factors, and course of alzheimer’s disease , 1999, Biological Psychiatry.
[28] Hans Förstl,et al. [Incidence and importance of "non-cognitive" symptoms in dementia of the Alzheimer type: productive psychotic symptoms, depressive disorders and behavioral disorders]. , 1993, Zeitschrift fur Gerontologie.
[29] K. Marder,et al. The Columbia University Scale for Psychopathology in Alzheimer's disease. , 1992, Archives of neurology.
[30] J. Cummings,et al. Assessment of Cognitive, Psychiatric, and Behavioral Disturbances in Patients with Dementia: The Neurobehavioral Rating Scale , 1992, Journal of the American Geriatrics Society.
[31] J. Moossy,et al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. , 1991, Archives of neurology.
[32] H. Sackeim,et al. Behavioral Syndromes in Alzheimer's Disease , 1992, International Psychogeriatrics.
[33] F. Bymaster,et al. Elucidating the role of muscarinic receptors in psychosis. , 2001, Life sciences.
[34] Wayne C. Drevets,et al. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type , 1989, Biological Psychiatry.
[35] H. Sackeim,et al. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. , 1998, The American journal of psychiatry.
[36] A. Kurz,et al. DELUSIONS AND HALLUCINATIONS IN ALZHEIMER'S DISEASE: RESULTS FROM A TWO‐YEAR LONGITUDINAL STUDY , 1996 .
[37] R. Young,et al. AGE AND PSYCHOSIS IN DEGENERATIVE DEMENTIA , 1997, International journal of geriatric psychiatry.
[38] S. Lovestone,et al. Clinical predictors of aggressive behaviour in Alzheimer's disease , 1998, International journal of geriatric psychiatry.
[39] Robert P. Friedland,et al. Dementia: A Clinical Approach (2nd Ed.) , 1992 .
[40] L. Schneider,et al. A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia , 1990, Journal of the American Geriatrics Society.
[41] Jeffrey L. Cummings,et al. The spectrum of behavioral changes in Alzheimer's disease , 1996, Neurology.
[42] B. Gulanski,et al. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease , 1998, Neurology.
[43] D. Benson,et al. Dementia: A Clinical Approach , 1983 .
[44] P J Whitehouse,et al. Psychiatric symptoms associated with Alzheimer's disease. , 1990, The Journal of neuropsychiatry and clinical neurosciences.
[45] J. Cummings,et al. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. , 1995, The Journal of neuropsychiatry and clinical neurosciences.
[46] D. Collier,et al. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation , 2001, Journal of neurology, neurosurgery, and psychiatry.
[47] J. Cummings,et al. Cholinesterase inhibitors: A new class of psychotropic compounds. , 2000, The American journal of psychiatry.
[48] R. Mayeux,et al. Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. , 1991, Archives of neurology.
[49] D. Jeste,et al. Cognitive deficits of patients with Alzheimer's disease with and without delusions. , 1992, The American journal of psychiatry.
[50] D. Jeste,et al. Overview of depression and psychosis in Alzheimer's disease. , 1989, The American journal of psychiatry.
[51] Hans Förstl,et al. Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findings , 1993, Acta psychiatrica Scandinavica.
[52] J. Cummings,et al. Depressive Symptoms in Alzheimer Disease: Assessment and Determinants , 1995, Alzheimer disease and associated disorders.
[53] S H Ferris,et al. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. , 1987, The Journal of clinical psychiatry.
[54] J. Miller,et al. Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. , 2000, Archives of general psychiatry.
[55] Jiska Cohen-Mansfield,et al. Nonpharmacologic Interventions for Inappropriate Behaviors in Dementia: A Review, Summary, and Critique , 2001 .
[56] Jane S. Paulsen,et al. Incidence of and risk factors for hallucinations and delusions in patients with probable AD , 2000, Neurology.
[57] D. Jeste,et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. , 1999, The Journal of clinical psychiatry.
[58] M. Haupt,et al. Presentation and stability of noncognitive symptom patterns in patients with Alzheimer disease. , 1998, Alzheimer disease and associated disorders.
[59] H. Spinnler,et al. Variables linked to psychotic symptoms in Alzheimer's disease , 1998, European journal of neurology.
[60] C. Sadowsky,et al. Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease. , 1997, Archives of neurology.
[61] M F Weiner,et al. The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. , 1995, The American journal of psychiatry.
[62] M. Folstein,et al. Psychosis and physical aggression in probable Alzheimer's disease. , 1991, The American journal of psychiatry.
[63] G. Frisoni,et al. Temporal lobe asymmetry in patients with Alzheimer's disease with delusions , 2000, Journal of neurology, neurosurgery, and psychiatry.
[64] P. S. St George-Hyslop,et al. Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. , 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[65] J. Cummings,et al. Neuropsychiatric Symptoms and Cholinergic Therapy for Alzheimer’s Disease , 1999, Gerontology.
[66] J. Becker,et al. The apolipoprotein E ϵ4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease , 1997, Neurology.
[67] C. Lyketsos,et al. The relationship between delusions and depression in Alzheimer's disease , 2002, International journal of geriatric psychiatry.
[68] B. Lawlor,et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia , 1999, Neurology.
[69] G. Lenzi,et al. Delusions and dementia: clinical and CT correlates , 1995, Acta neurologica Scandinavica.
[70] A. Kurz,et al. Predictors of nursing home placement in patients with alzheimer's disease , 1993 .
[71] C. Ballard,et al. Associations of Psychotic Symptoms in Dementia Sufferers , 1995, British Journal of Psychiatry.
[72] D. Drachman,et al. The Caretaker Obstreperous‐Behavior Rating Assessment (COBRA) Scale , 1992, Journal of the American Geriatrics Society.
[73] C. Lyketsos,et al. Isolated hallucinosis in Alzheimer's disease is associated with African–American race , 2002, International journal of geriatric psychiatry.
[74] S. Gauthier,et al. Validity and Reliability of the Dementia Behavior Disturbance Scale , 1990, Journal of the American Geriatrics Society.
[75] D. Jeste,et al. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[76] C. Lyketsos,et al. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study , 2001, International journal of geriatric psychiatry.
[77] A. Kurz,et al. A 2-Year Follow-Up of Behavioural and Psychological Symptoms in Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.
[78] T. Shimomura,et al. Factors associated with psychotic symptoms in Alzheimer’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.
[79] C. Lyketsos,et al. Relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias. , 1998, The Journal of neuropsychiatry and clinical neurosciences.
[80] R. Tamura,et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group. , 2000, Archives of general psychiatry.
[81] T Hope,et al. The Present Behavioural Examination (PBE): the development of an interview to measure current behavioural abnormalities , 1992, Psychological Medicine.
[82] Philip D. Harvey,et al. Noncognitive Disturbances in Alzheimer's Disease: Frequency, Longitudinal Course, and Relationship to Cognitive Symptoms , 1997, Journal of the American Geriatrics Society.
[83] M. Albert,et al. The course of psychopathologic features in mild to moderate Alzheimer disease. , 1997, Archives of general psychiatry.
[84] B. Miller,et al. Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease. , 1996, The American journal of psychiatry.
[85] J. Cohen-Mansfield,et al. Delusions and hallucinations in an adult day care population. A longitudinal study. , 1998, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[86] T. Hope,et al. Manchester and Oxford Universities Scale for the Psychopathological Assessment of Dementia (MOUSEPAD) , 1996, British Journal of Psychiatry.
[87] G. Peavy,et al. An instrumental study of the relationship between extrapyramidal signs and psychosis in Alzheimer's disease. , 2000, The Journal of neuropsychiatry and clinical neurosciences.
[88] R. Leiguarda,et al. Prevalence and correlates of aggressive behavior in Alzheimer's disease. , 1998, The Journal of neuropsychiatry and clinical neurosciences.
[89] D. Leo,et al. Delusions in Alzheimer's disease and multi‐infarct dementia , 1993, Acta neurologica Scandinavica.
[90] M. Mega,et al. The Neuropsychiatric Inventory , 1994, Neurology.
[91] J. Morris,et al. Psychopathology in younger versus older persons with very mild and mild dementia of the Alzheimer type. , 1993, The American journal of psychiatry.
[92] D. Devanand. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease. , 1999, Alzheimer disease and associated disorders.
[93] C. Lyketsos,et al. Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates , 2000, International journal of geriatric psychiatry.
[94] J. Cummings. Psychosis in neurologic disease : neurobiology and pathogenesis : Psychosis in neurologic diseases , 1992 .
[95] R. Ownby,et al. Concomitants of visual hallucinations in Alzheimer's disease , 1994, Neurology.
[96] Alistair Burns. Assessment scales in old age psychiatry , 1999 .
[97] C. Lyketsos,et al. An evidence‐based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease , 2001, International journal of geriatric psychiatry.
[98] Acute agitation and other behaviors associated with Wernicke aphasia and their possible neurological bases , 1993 .
[99] O. Lopez,et al. Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. , 1998, Archives of neurology.
[100] C. Lyketsos,et al. Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype. , 1997, The Journal of neuropsychiatry and clinical neurosciences.
[101] R. Levy,et al. Neuropathological Correlates of Psychotic Phenomena in Confirmed Alzheimer's Disease , 1994, British Journal of Psychiatry.
[102] P. Haddad,et al. Visual Hallucinations as the Presenting Symptom of Senile Dementia , 1992, British Journal of Psychiatry.
[103] Richard J Martin,et al. Assessment of Behavioral and Affective Symptoms in Alzheimer's Disease , 1990, Journal of geriatric psychiatry and neurology.
[104] D. Bennett,et al. Hallucinations and associated factors in Alzheimer's disease. , 1991, The Journal of neuropsychiatry and clinical neurosciences.
[105] E. Rubin. Delusions as part of Alzheimer's disease : Psychosis in neurologic diseases , 1992 .
[106] P. Tariot,et al. Long-Term use of quetiapine in elderly patients with psychotic disorders. , 2000, Clinical therapeutics.
[107] S. Wisniewski,et al. Alterations of striatal dopamine receptor binding in Alzheimer disease are associated with Lewy body pathology and antemortem psychosis. , 2001, Archives of neurology.
[108] L A Beckett,et al. Hallucinations, delusions, and cognitive decline in Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.
[109] Constantine G. Lyketsos,et al. Practical Dementia Care , 1999 .
[110] K. Kotrla,et al. Clinical variables associated with psychosis in Alzheimer's disease. , 1995, The American journal of psychiatry.
[111] J. Cummings,et al. Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. , 1996, The American journal of psychiatry.
[112] J. Cummings,et al. Delusions in dementia syndromes: investigation of behavioral and neuropsychological correlates. , 1991, The Journal of neuropsychiatry and clinical neurosciences.
[113] K. Lapane,et al. Gender differences in the treatment of behavior problems in Alzheimer’s disease , 2000, Neurology.